GLIMESTAR PM 1

Glimestar-PM1 Tablet ER is a combination medication designed to assist in the management of blood glucose levels. It is intended for use in conjunction with a balanced diet and regular physical activity to enhance blood sugar regulation in adults diagnosed with type 2 diabetes mellitus. This medication promotes the effective use of insulin within the body, contributing to the reduction of elevated blood sugar levels. It is essential to follow your healthcare provider’s instructions regarding the appropriate dosage and duration of use. Glimestar-PM1 should be taken with meals to minimize the risk of gastrointestinal discomfort. In the event that a dose is missed, it should be taken as soon as it is remembered, unless it is close to the time for the next scheduled dose; in such cases, the missed dose should be skipped, and the regular dosing routine should be resumed. Doubling doses is discouraged as it may result in hypoglycemia, a condition characterized by abnormally low blood sugar levels. Some individuals may experience hypoglycemia, especially when this medication is combined with other diabetes medications, alcohol, or when meals are missed. Regular monitoring of blood sugar levels is recommended during treatment. Other potential side effects include nausea, diarrhea, abdominal discomfort, headaches, fractures, and respiratory infections. Prior to initiating therapy with this medication, it is important to inform your healthcare provider about any pre-existing kidney, liver, or heart conditions. Pregnant or nursing women should seek medical advice before proceeding with this treatment. Kidney function tests may be performed by your physician prior to starting the medication, and it is advisable to limit alcohol intake due to the heightened risk of adverse effects.